![PRD_000555 PRD_000555](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000555.svg) | PRD_000555 | Name: | AERUGINOSIN 298-A | Formula: | C30 H48 N6 O7 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_002098 PRD_002098](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002098.svg) | PRD_002098 | Formula: | C29 H43 N10 O9 | Definition date: | 2013-08-07 | Last modified: | 2023-11-03 |
|
![PRD_002239 PRD_002239](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002239.svg) | PRD_002239 | Name: | N-[5-(2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoyl]-L-valyl-L-leucyl-N-[(3R)-7-amino-2-oxoheptan-3-yl]-L-threoninamide | Formula: | C32 H57 N7 O7 S | Definition date: | 2017-08-02 | Last modified: | 2023-11-03 |
|
![PRD_002282 PRD_002282](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002282.svg) | PRD_002282 | Name: | (3S,6S,9S,15aR)-6,9-dibenzyl-3-{6,6-dihydroxy-6-[(2S)-oxiran-2-yl]hexyl}octahydro-2H-pyrido[1,2-a][1,4,7,10]tetraazacyclododecine-1,4,7,10(3H,12H)-tetrone | Formula: | C34 H44 N4 O7 | Definition date: | 2017-09-13 | Last modified: | 2023-11-03 |
|
![PRD_002289 PRD_002289](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002289.svg) | PRD_002289 | Name: | 3-[(3R,6S,9S,12S,15S,18S,21S,24R,27S)-21-(2-amino-2-oxoethyl)-9-(3-aminopropyl)-3,24,27-tribenzyl-15-[(4-hydroxyphenyl)methyl]-6-(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29-decaoxo-12-(propan-2-yl)-2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29-octacosahydro-1H-1,4,7,10,13,16,19,22,25,28-benzodecaazacyclohentriacontin-18-yl]propanamide | Formula: | C68 H85 N13 O13 | Definition date: | 2020-08-12 | Last modified: | 2023-11-03 |
|
![PRD_002290 PRD_002290](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002290.svg) | PRD_002290 | Name: | 4-[(3R,6S,9S,12S,15S,18S,21S,24R,27S)-21-(2-amino-2-oxoethyl)-9-(3-aminopropyl)-3,24,27-tribenzyl-15-[(4-hydroxyphenyl)methyl]-6-(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29-decaoxo-12-(propan-2-yl)-2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29-octacosahydro-1H-1,4,7,10,13,16,19,22,25,28-benzodecaazacyclohentriacontin-18-yl]butan-1-aminium | Formula: | C69 H90 N13 O12 | Definition date: | 2020-08-12 | Last modified: | 2023-11-03 |
|
![PRD_000727 PRD_000727](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000727.svg) | PRD_000727 | Name: | PYOVERDIN G173 Fe Complex | Formula: | C49 H66 Fe N13 O21 | Description: | IN IRON-DEFICIENT CONDITIONS, PSEUDOMONAS
AERUGINOSA SECRETES A MAJOR FLUORESCENT
SIDEROPHORE NAMED PYOVERDIN (PVD),
WHICH AFTER CHELATING IRON(III) IS TRANSPORTED
BACK INTO THE CELL VIA ITS OUTER MEMBRANE RECEPTOR
FPVA. FPVA IS A TONB-DEPENDENT TRANSPORT PROTEIN
AND HAS THE ABILITY TO BIND PVD IN ITS APO-
OR IRON-LOADED FORM. | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000842 PRD_000842](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000842.svg) | PRD_000842 | Name: | PTA-SFTI INHIBITOR | Formula: | C66 H106 N20 O18 S2 | Description: | Bowman-Birk Inhibitor | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000846 PRD_000846](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000846.svg) | PRD_000846 | Name: | TRYPSIN INHIBITOR 1 | Formula: | C66 H106 N20 O18 S2 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000117 PRD_000117](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000117.svg) | PRD_000117 | Name: | ARYLOMYCIN A2 | Formula: | C42 H60 N6 O11 | Description: | ARYLOMYCIN A2 IS A BIARYL-BRIDGED LIPOPEPTIDE. THE SCAFFOLD IS MADE OF TWO PARTS: (1) N-TERM EXOCYCLIC TRIPEPTIDE (2)
A TRICYCLIC PEPTIDE, WITH [3,3] BIARYL BOND BETWEEN RESIDUE 4 AND 6 AN ISO-C12 FATTY ACID IS LINKED TO RESIDUE 1. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000142 PRD_000142](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000142.svg) | PRD_000142 | Name: | Cyclosporin A | Formula: | C62 H111 N11 O12 | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000143 PRD_000143](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000143.svg) | PRD_000143 | Name: | Cyclosporin D | Formula: | C64 H115 N11 O12 S | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
CYCLOSPORIN D IS A NATURAL ANALOG OF CYCLOSPORIN A,
OBTAINED FROM A DIFFERENT NUTRIENT BROTH AND
DIFFERS FROM CYCLOSPORIN IN RESIDUE 6 (ABA6VAL). | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000144 PRD_000144](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000144.svg) | PRD_000144 | Name: | Cyclosporin C | Formula: | C62 H111 N11 O13 | Description: | CYCLOSPORIN C IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
CYCLOSPORIN C IS A NATURAL ANALOG OF CYCLOSPORIN A,
OBTAINED FROM A DIFFERENT NUTRIENT BROTH AND DIFFERS
FROM CYCLOSPORIN A IN RESIDUE 6 (ABA6THR). | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000150 PRD_000150](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000150.svg) | PRD_000150 | Name: | GRAMICIDIN A | Formula: | C99 H140 N20 O17 | Description: | GRAMICIDIN A IS A HEXADECAMERIC HELICAL PEPTIDE
WITH ALTERNATING D,L CHARACTERISTICS.
THE N-TERM IS FORMYLATED (RESIDUE 0).
THE C-TERM IS CAPPED WITH ETHANOLAMINE (RESIDUE 16). | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000151 PRD_000151](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000151.svg) | PRD_000151 | Name: | GRAMICIDIN B | Formula: | C97 H139 N19 O17 | Description: | GRAMICIDIN B IS A HEXADECAMERIC HELICAL PEPTIDE
WITH ALTERNATING D,L CHARACTERISTICS.
THE N-TERM IS FORMYLATED (RESIDUE 0).
THE C-TERM IS CAPPED WITH ETHANOLAMINE (RESIDUE 16). | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000152 PRD_000152](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000152.svg) | PRD_000152 | Name: | GRAMICIDIN D | Formula: | C99 H140 N20 O17 | Description: | GRAMICIDIN D IS A HEXADECAMERIC HELICAL PEPTIDE
WITH ALTERNATING D,L CHARACTERISTICS.
THE N-TERM IS FORMYLATED (RESIDUE 1).
THE C-TERM IS CAPPED WITH ETHANOLAMINE (RESIDUE 16). | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000153 PRD_000153](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000153.svg) | PRD_000153 | Name: | GRAMICIDIN C | Formula: | C99 H140 N20 O17 | Description: | GRAMICIDIN C IS A HEXADECAMERIC HELICAL PEPTIDE
WITH ALTERNATING D,L CHARACTERISTICS.
THE N-TERM IS FORMYLATED (RESIDUE 0).
THE C-TERM IS CAPPED WITH ETHANOLAMINE (RESIDUE 16). | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000154 PRD_000154](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000154.svg) | PRD_000154 | Name: | MINI-GRAMICIDIN A DIMER | Formula: | C168 H226 N32 O26 | Description: | THE N-TERMINI OF THE TWO IDENTICAL PEPTIDES, EACH
A TRUNCATED GRAMICIDIN A WERE LINKED BY A SUCCINIC
ACID IN A HEAD-TO-HEAD MANNER. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000155 PRD_000155](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000155.svg) | PRD_000155 | Name: | MINI-GRAMICIDIN A - GRAMICIDIN A DIMER | Formula: | C180 H244 N34 O30 | Description: | THE N-TERMINI OF THE TWO PEPTIDES, EACH A
TRUNCATED GRAMICIDIN A, WERE LINKED BY A SUCCINIC
ACID IN A HEAD-TO-HEAD MANNER. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000156 PRD_000156](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000156.svg) | PRD_000156 | Name: | Cephaibol A | Formula: | C82 H127 N17 O20 | Description: | CEPHAIBOL A IS A HEXADECAMERIC HELICAL PEPTIDE.
THE N-TERM IS ACETYLATED (RESIDUE 0) | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000157 PRD_000157](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000157.svg) | PRD_000157 | Name: | Cephaibol B | Formula: | C83 H129 N17 O20 | Description: | CEPHAIBOL A IS A HEXADECAMERIC HELICAL PEPTIDE.
THE N-TERM IS ACETYLATED (RESIDUE 0) | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000158 PRD_000158](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000158.svg) | PRD_000158 | Name: | Cephaibol C | Formula: | C82 H127 N17 O20 | Description: | CEPHAIBOL C IS A HEXADECAMERIC HELICAL PEPTIDE.
THE N-TERM IS ACETYLATED (RESIDUE 0) | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000159 PRD_000159](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000159.svg) | PRD_000159 | Name: | Zervamicin IIB | Formula: | C90 H139 N19 O22 | Description: | ZERVAMICIN IS A HEXADECAMERIC HELICAL PEPTIDE.
THE N-TERM IS ACETYLATED (RESIDUE 0) | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000160 PRD_000160](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000160.svg) | PRD_000160 | Name: | TRICHOTOXIN A50E | Formula: | C78 H136 N20 O21 | Description: | TRICHOTOXIN_A50E IS AN OCTADECAMERIC HELICAL PEPTIDE.
THE N-TERM IS ACETYLATED (RESIDUE 0) | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000161 PRD_000161](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000161.svg) | PRD_000161 | Name: | Antiamoebin 1 | Formula: | C82 H127 N17 O20 | Description: | ANTIAMOEBIN I IS A HEXADECAMERIC HELICAL PEPTIDE.
THE N-TERM IS ACETYLATED (RESIDUE 0) | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|